Cassava Sciences, Inc. Appoints Richard J. Barry to Board of Directors, as Chair of the Nominating and Governance Committee and as Chair of the Audit Committee of the Board
June 14, 2021 at 01:30 pm
Share
Cassava Sciences, Inc. announced the appointment of Mr. Richard (Rick) Barry to the company’s Board of Directors, effective June 11, 2021. Mr. Barry personally owns 150,000 shares of SAVA, the Company’s common stock. His shares were purchased in the open market in 2021, prior to engaging into confidential discussions with the Company regarding a Board position. Mr. Barry has extensive experience in the investment management business. He was a founding member of Eastbourne Capital Management LLC, a large equity hedge fund investing in health care and a variety of other industries and served as a Managing General Partner and Portfolio Manager from 1999 to its close in 2010. The Board also appointed Mr. Barry as Chair of the Nominating and Governance Committee and as Chair of the Audit Committee of the Board.
Cassava Sciences, Inc. is a biotechnology company focused on Alzheimer's disease. The Company's science is based on stabilizing, but not removing, a critical protein in the brain. The Company is focused on its product discovery and development efforts on disorders of the nervous system. Its lead therapeutic drug candidate, simufilam, is under clinical evaluation for the proposed treatment of Alzheimer's disease dementia in Phase 3 clinical studies. The Company has two biopharmaceutical assets under development. Its lead therapeutic product candidate, called simufilam, is an oral treatment for Alzheimer's disease dementia. Its lead investigational diagnostic product candidate, called SavaDx, is a way to detect the presence of Alzheimer's disease from a small sample of blood. Simufilam targets an altered form of a protein called filamin A in the Alzheimer's brain. It owns rights to its drug and diagnostic assets and related technologies, without royalty obligations to any third party.
Cassava Sciences, Inc. Appoints Richard J. Barry to Board of Directors, as Chair of the Nominating and Governance Committee and as Chair of the Audit Committee of the Board
CASSAVA SCIENCES, INC. 
